WithdrawnNCT03182049
Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study
Studying Granulomatosis with polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Alexander Gelbard, MDVanderbilt University Medical Center
- Intervention
- Airway assessment(procedure)
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2023
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Collaborators
North American Airway Collaborative (NoAAC) · Vasculitis Patient Powered Research Network (VPPRN) · Vasculitis Clinical Research Consortium (VCRC)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03182049 on ClinicalTrials.govOther trials for Granulomatosis with polyangiitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06940661Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03919435TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With PolyangiitisUniversity of Pennsylvania
- ACTIVE NOT RECRUITINGPHASE3NCT01933724The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachUniversity of South Florida